Hedge fund billionaire Daniel Loeb reduced its exposure to life Sciences Tools & Services sector by cutting stake in Danaher Corporation (NYSE:DHR) and fully exiting position in Thermo Fisher Scientific Inc (NYSE:TMO) in the first quarter of 2026.
The investor reduced his stake in Danaher to 525,000 in the first quarter of 2026 from 600,000 in the fourth quarter of 2025. Meanwhile, he entirely sold a 50,000 stake in Thermo Fisher as of March 31, 2026.
DHR: Recent Key Events
Danaher reported adjusted earnings of $1.94 per share on Tuesday, beating the analyst consensus estimate of $1.83.
Revenue rose 5.5% year over year to $6.27 billion, ahead of analysts’ expectations of $6.10 billion.
